Search
Facial Treatments
Body Treatments
Injectables
Plastic Surgery
Your Esthetic Advisor
Beauty and Lifestyle Magazine
Facial Treatments
Body Treatments
Injectables
Plastic Surgery
Home
Tags
SHAREHOLDER
Tag: SHAREHOLDER
Injectables
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – RVNC – WECT
Esthetic Advisor
-
November 7, 2023
0
Injectables
Revance Therapeutics, Inc. is now a shareholder of Handelsbanken … – Best Stocks
Esthetic Advisor
-
March 18, 2023
0
Injectables
Revance Therapeutics, Inc. is now a shareholder of Handelsbanken Fonder AB (NASDAQ:RVNC)
Esthetic Advisor
-
January 16, 2023
0
Injectables
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Revance Therapeutics, Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022
Esthetic Advisor
-
August 25, 2022
0
Facial Treatments
Springs Rejuvenation Inc. Provides Shareholder Update | 2022-03-24 | Press Releases
Esthetic Advisor
-
March 26, 2022
0
Facial Treatments
Springs Rejuvenation Inc. Provides Shareholder Update
Esthetic Advisor
-
March 24, 2022
0
Injectables
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Revance Therapeutics, Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022
Esthetic Advisor
-
March 21, 2022
0
Injectables
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Revance Therapeutics, Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022
Esthetic Advisor
-
March 18, 2022
0
Injectables
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Revance Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 – RVNC | 2022-01-25 | Press Releases
Esthetic Advisor
-
March 17, 2022
0
Injectables
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline
Esthetic Advisor
-
March 7, 2022
0
1
2
Page 1 of 2
